Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bright Minds Biosciences (DRUG) Cash from Financing Activities: 2019-2021

Historic Cash from Financing Activities for Bright Minds Biosciences (DRUG) over the last 1 years, with Sep 2021 value amounting to -$7,706.

  • Bright Minds Biosciences' Cash from Financing Activities fell 101.11% to -$7,706 in Q3 2021 from the same period last year, while for Sep 2021 it was $20.5 million, marking a year-over-year change of. This contributed to the annual value of $595,934 for FY2024, which is 63.31% down from last year.
  • As of Q3 2021, Bright Minds Biosciences' Cash from Financing Activities stood at -$7,706, which was up 98.26% from -$443,822 recorded in Q2 2021.
  • In the past 5 years, Bright Minds Biosciences' Cash from Financing Activities registered a high of $19.5 million during Q1 2021, and its lowest value of -$443,822 during Q2 2021.
  • In the last 3 years, Bright Minds Biosciences' Cash from Financing Activities had a median value of $393,905 in 2019 and averaged $3.6 million.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first spiked by 652.33% in 2020, then plummeted by 101.11% in 2021.
  • Over the past 3 years, Bright Minds Biosciences' Cash from Financing Activities (Quarterly) stood at $92,431 in 2019, then soared by 652.33% to $1.5 million in 2020, then tumbled by 101.11% to -$7,706 in 2021.
  • Its Cash from Financing Activities stands at -$7,706 for Q3 2021, versus -$443,822 for Q2 2021 and $19.5 million for Q1 2021.